Question 1

Does Beacon Pointe Advisors own IBRX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Beacon Pointe Advisors holds 73,497 shares of IBRX (Immunitybio), worth $643,467.

Question 2

How many shares of IBRX does Beacon Pointe Advisors own?

Accepted Answer

As of its Q2 2026 13F, Beacon Pointe Advisors holds 73,497 shares of IBRX (Immunitybio).

Question 3

What is Beacon Pointe Advisors' IBRX position worth?

Accepted Answer

As of its Q2 2026 13F, Beacon Pointe Advisors' IBRX position is worth $643,467.

Question 4

Is Beacon Pointe Advisors buying or selling IBRX?

Accepted Answer

In Q2 2026, Beacon Pointe Advisors increased its IBRX position by 33,270 shares (+82.7%).

Question 5

When did Beacon Pointe Advisors first buy IBRX?

Accepted Answer

Beacon Pointe Advisors first reported IBRX in its Q3 2023 13F and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	73,497	+82.7%	$643,467	0.0%	$8.76	38
2026-Q1	Increased	40,227	+25.5%	$308,542	0.0%	$7.67	29
2025-Q4	Decreased	32,046	-3.0%	$63,452	0.0%	$1.98	0
2025-Q3	Increased	33,042	+26.9%	$81,284	0.0%	$2.46	26
2025-Q2	Unchanged	26,042	0.0%	$68,751	0.0%	$2.64	0
2025-Q1	Unchanged	26,042	0.0%	$78,386	0.0%	$3.01	0
2024-Q4	Unchanged	26,042	0.0%	$66,668	0.0%	$2.56	0
2024-Q3	Unchanged	26,042	0.0%	$96,876	0.0%	$3.72	0